These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4164914)

  • 1. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinuclear factors, rheumatoid factors and Bordet-Wassermann reaction in chronic and systemic lupus erythematosus.
    Strejcek J; Malina L; Bielický T
    Acta Derm Venereol; 1968; 48(3):198-202. PubMed ID: 4176741
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulins G, A, and M in systemic lupus erythematosus. Relationship to serum complement titer, latex titer, antinuclear antibody, and manifestations of clinical disease.
    Cass RM; Mongan ES; Jacox RF; Vaughan JH
    Ann Intern Med; 1968 Oct; 69(4):749-56. PubMed ID: 4176198
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antinuclear factor, phenomena of the LE cells and complement in systemic erythematosus].
    Okuda M
    Nihon Rinsho; 1968 Dec; 26(12):3438-48. PubMed ID: 4181083
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-nuclear factors in rheumatoid arthritis, systemic lupus erythematosus and other diseases. Re-evaluation of the nucleoprotein complement fixation technique and anti-complementary activity.
    Onodera S; Schubart AF; Ewald RW; Heuckenkamp PU
    J Chronic Dis; 1966; 19(11):1133-44. PubMed ID: 5297998
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complement-binding DNA antibodies in patients with LED--an index for pathological activity].
    Fjellström KE; Wallentin L; Hood B
    Nord Med; 1971 Jul; 86(27):833-4. PubMed ID: 5314751
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma].
    Meyer zum Büschenfelde ; Talke H; Holzmann H
    Arch Klin Exp Dermatol; 1967; 228(4):396-407. PubMed ID: 4171697
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biopathology of disseminated lupus erythematosus].
    Youinou P; Amoura Z
    Rev Prat; 1998 Mar; 48(6):603-8. PubMed ID: 9781129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on nucleoprotein determinants for systemic lupus erythematosus serum.
    Stollar BD
    J Immunol; 1967 Nov; 99(5):959-65. PubMed ID: 5299610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute lupus erythematosus with total absence of the C4 fraction of complement].
    Hauptmann G; Grosshans E; Heid E; Mayer S; Basset A
    Nouv Presse Med; 1974 Apr; 3(14):881-2. PubMed ID: 4601861
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of antinuclear factor reaction by chloroquine.
    Bencze G; Johnson GD
    Immunology; 1965 Aug; 9(2):201-2. PubMed ID: 5320159
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies.
    Frost PG; Lachmann PJ
    Clin Exp Immunol; 1968 Jun; 3(5):447-55. PubMed ID: 5662583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus.
    Gonzalez EN; Rothfield NF
    N Engl J Med; 1966 Jun; 274(24):1333-8. PubMed ID: 4160639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions].
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta; 1967; 34(1):Suppl:141-2. PubMed ID: 5301522
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polyanions inhibit the binding of autoantibodies with some cellular proteins].
    Griaznova IuB; Kabakov AE; Brovkina LN; Saenko VA; Nasonov EL; Poverennyĭ AM
    Biull Eksp Biol Med; 1990 Jul; 110(7):75-6. PubMed ID: 2224111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta; 1967 Dec; 34(1):5-22. PubMed ID: 4173836
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-immunological parallels in systemic lupus erythematosus].
    Drampian FS; Aznaurian AV
    Zh Eksp Klin Med; 1971; 11(1):101-4. PubMed ID: 5315376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.